Frequently Asked Questions (FAQs)
Our complete semaglutide vs tirzepatide comparison guide covers this in detail, but here are the key differences in weight loss outcomes: Average Weight Loss Comparison Semaglutide (STEP-1 trial, 68 weeks): Average weight loss: 14.9% 69.1% lost 10% or more 50.5% lost 15% or more Tirzepatide (SURMOUNT-1 trial, 72 weeks at 15 mg dose): Average weight loss: 22.5% 89% lost 10% or more 78% lost 15% or more Tirzepatide shows higher average weight loss in clinical trials, though both medications demonstrate significant effectiveness
4953 Liraglutide Liraglutide, developed by Novo Nordisk in Denmark, is currently the most widely used daily formulation of GLP-1RA, with a half-life of 13 h
Formula: C12H19N3O7S Storage condition: Store in cool place and keep container away from sunlight
Whilst generally well-tolerated and effective at improving glycaemic control, concerns have emerged regarding a potential association with pancreatitisa serious inflammatory condition of the pancreas
After learning the facts, you now understand that losing 20-34% of your weight loss as muscle isn't just a minor side effect